Wiley-VCH, 2014. — 326 p. — ISBN: 9783527333646
In 1999, Gisbert Schneider coined the term “scaffold hopping” for a systematic approach to modify the molecular skeleton of a lead structure. Whereas in bioisosteric replacement atoms or small groups are substituted by other ones with identical or at least similar stereoelectronic features, scaffold hopping exchanges the central part of a molecule by a molecular frame of similar shape and pharmacophoric pattern. Correspondingly, scaffold hopping may be considered as an extension of bioisosteric replacement. In this manner, it provides a conceptual and practical route for generating new chemistry and lead series with higher efficacy, better or modified selectivity, and/or improved pharmacokinetic properties, based on known active principles.
As often in science, this approach is also not completely new. The modification or exchange of a molecular scaffold was already applied in the chemical variation of morphine, quinine, some steroid hormones (e.g., estradiol), and b-blockers, to list only a few examples. Looking at naturally occurring b-lactams, that is, the penicillins, cephalosporins, and monobactams, we see tha also nature some times uses this principle. Like in “fragment-based design,” where a breakthrough came only after the description of the advantages of this method, the definition “scaffold hopping” appealed medicinal chemists to use this strategy – and fueled its systematic application in lead structure search and optimization. Marketed analogs of celecoxib (Celebrex 1 ), sildenafil (Viagra 1 ), and several kinase inhibitors are recent examples of drugs and clinical candidates resulting from this approach.
Scaffolds: Identification, Representation Diversity, and NavigationIdentifying and Representing Scaffolds
Markush Structures and Chemical Patents
Scaffold Diversity in Medicinal Chemistry Space
Scaffold Mining of Publicly Available Compound Data
Exploring Virtual Scaffold Spaces
Scaffold-Hopping MethodsSimilarity-Based Scaffold Hopping Using 2D Fingerprints
CATS for Scaffold Hopping in Medicinal Chemistry
Reduced Graphs
Feature Trees
Feature Point Pharmacophores (FEPOPS)
Three-Dimensional Scaffold Replacement Methods
Spherical Harmonic Molecular Surfaces (ParaSurf and ParaFit)
The XED Force Field and Spark
Molecular Interaction Fingerprints
SkelGen
Case StudiesScaffold Hopping for T-Type Calcium Channel and Glycine Transporter Type 1 Inhibitors
Bioisosteric Replacements for the Neurokinin 1 Receptor (NK1R)
Fragment Hopping to Design Highly Potent and Selective Neuronal Nitric Oxide Synthase Inhibitors